levers semaglutide Retatrutide, a triple agonist, delivered 30.3% weight loss at two years in Phase 3. The headlines state: → 70 lbs average loss on 12mg at 80 weeks (28.3% of body weight) → Semaglutide Shows Major Promise for

GLP-1 medications don't just slow stomach emptying and suppress appetite

Though these medications are not currently FDA-approved for PCOS, a couple studies have found that in people with the condition who also have a higher weight, the drugs dont just have a weight-loss effect but can also alleviate PCOS-specific symptoms like cycle abnormalities

Bian: Im not currently worried, and Ive personally been on tirzepatide for weight loss for the last two years

The recent cardiovascular safety storm has nothing to do with it

Ensure your email and phone number are accurate to receive timely updates and prevent delays in your treatment